Mirela F. Zaltariov
New Iminodiacetate–Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity
Zaltariov, Mirela F.; Hammerstad, Marta; Arabshahi, Homayon J.; Jovanović, Katarina; Richter, Klaus W.; Cazacu, Maria; Shova, Sergiu; Balan, Mihaela; Andersen, Niels H.; Radulović, Siniša; Reynisson, Jóhannes; Andersson, K. Kristoffer; Arion, Vladimir B.
Authors
Marta Hammerstad
Homayon J. Arabshahi
Katarina Jovanović
Klaus W. Richter
Maria Cazacu
Sergiu Shova
Mihaela Balan
Niels H. Andersen
Siniša Radulović
Johannes Reynisson j.reynisson@keele.ac.uk
K. Kristoffer Andersson
Vladimir B. Arion
Abstract
As ribonucleotide reductase (RNR) plays a crucial role in nucleic acid metabolism, it is an important target for anticancer therapy. The thiosemicarbazone Triapine is an efficient R2 inhibitor, which has entered ∼20 clinical trials. Thiosemicarbazones are supposed to exert their biological effects through effectively binding transition-metal ions. In this study, six iminodiacetate–thiosemicarbazones able to form transition-metal complexes, as well as six dicopper(II) complexes, were synthesized and fully characterized by analytical, spectroscopic techniques (IR, UV–vis; 1H and 13C NMR), electrospray ionization mass spectrometry, and X-ray diffraction. The antiproliferative effects were examined in several human cancer and one noncancerous cell lines. Several of the compounds showed high cytotoxicity and marked selectivity for cancer cells. On the basis of this, and on molecular docking calculations one lead dicopper(II) complex and one thiosemicarbazone were chosen for in vitro analysis as potential R2 inhibitors. Their interaction with R2 and effect on the Fe(III)2-Y· cofactor were characterized by microscale thermophoresis, and two spectroscopic techniques, namely, electron paramagnetic resonance and UV–vis spectroscopy. Our findings suggest that several of the synthesized proligands and copper(II) complexes are effective antiproliferative agents in several cancer cell lines, targeting RNR, which deserve further investigation as potential anticancer drugs.
Citation
Zaltariov, M. F., Hammerstad, M., Arabshahi, H. J., Jovanović, K., Richter, K. W., Cazacu, M., Shova, S., Balan, M., Andersen, N. H., Radulović, S., Reynisson, J., Andersson, K. K., & Arion, V. B. (2017). New Iminodiacetate–Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity. Inorganic Chemistry, 56(6), 3532-3549. https://doi.org/10.1021/acs.inorgchem.6b03178
Journal Article Type | Article |
---|---|
Online Publication Date | Mar 2, 2017 |
Publication Date | Mar 20, 2017 |
Deposit Date | Jun 12, 2023 |
Journal | Inorganic Chemistry |
Print ISSN | 0020-1669 |
Electronic ISSN | 1520-510X |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 56 |
Issue | 6 |
Pages | 3532-3549 |
DOI | https://doi.org/10.1021/acs.inorgchem.6b03178 |
Keywords | Inorganic Chemistry; Physical and Theoretical Chemistry |
Public URL | https://keele-repository.worktribe.com/output/445843 |
You might also like
Accessing active fragments for drug discovery utilising nitroreductase biocatalysis.
(2024)
Journal Article
Phosphatidylcholine-Specific Phospholipase C as a Promising Drug Target
(2023)
Journal Article